All In Biotech

Drug Trial Radar · NCT01675648

Lofexidine for Inpatient Opiate Detox in Singapore

A Double-blind Randomised Controlled Clinical Trial of Lofexidine Versus Diazepam in the Management of the Opioid Withdrawal Syndrome During Inpatient Detoxification in Singapore

Last checked: Nov 20, 2026Latest source record: Aug 28, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 112 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

112

Actual

Start

Aug 2012

Primary completion

Jul 2015

Study completion Jul 2015

Sponsor

Lead sponsor
Institute of Mental Health, SingaporeAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Singapore Clinical Research Institute
First posted
Aug 30, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 21 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

In Singapore, opiate substitution medication e.g. methadone is only licensed for use with specific population. The standard treatment is one week of detoxification assisted with diazepam and symptomatic treatment followed by one week of rehabilitation. However, diazepam is highly addictive and widely abused among heroin users and pharmacologically, does not reduce the physical and psychological craving for opioids which can trigger relapse. Many opiate patients undergoing inpatient detoxification leave prematurely (i.e. PID: patient initiated discharge) because of the severity of unpleasant withdrawal symptoms. The purpose of the study is to establish an alternative medication to reduce opiate withdrawal symptoms for use in Singapore by evaluating the clinical efficacy of Lofexidine versus Diazepam in the management of the opiate withdrawal syndrome during inpatient detoxification.

Conditions

  • Opiate Dependent Patients Who Are Undergoing Inpatient Detoxification in Singapore

Interventions

  • LofexidineDrug

  • DiazepamDrug

  • Placebo for LofexidineDrug

  • Placebo for DiazepamDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate differences in OOWS (Objective Opiate Withdrawal Scale)Time frame: on day 3 and day 4 during inpatient dotex

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • National Addictions Management Service, Institute of Mental Health, Singapore

    Singapore, Singapore, Singapore

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.